-
公开(公告)号:DE3462688D1
公开(公告)日:1987-04-23
申请号:DE3462688
申请日:1984-12-10
Applicant: BASF AG
Inventor: KREISKOTT HORST PROF DR , SEITZ WERNER DR , RASCHACK MANFRED DR
IPC: C07B57/00 , A61K20060101 , A61K31/275 , A61P9/00 , C07B31/00 , C07C20060101 , C07C67/00 , C07C253/00 , C07C255/32 , C07C255/42 , C07C255/58 , C07D20060101 , C07C121/66
Abstract: 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane and its antipodes and salts are used for the treatment of diseases.
-
公开(公告)号:DE3243518A1
公开(公告)日:1984-05-30
申请号:DE3243518
申请日:1982-11-25
Applicant: BASF AG
Inventor: SEITZ WERNER DR , MICHEL ALFRED , TESCHENDORF HANS-JUERGEN DR ME , KREISKOTT HORST PROF DR , HOFMANN HANS PETER DR , TRAUT MARTIN DR
IPC: C07C225/18 , A61K31/135 , A61K31/205 , A61K31/395 , A61P25/24 , A61P25/26 , C07D207/08 , C07D211/32 , C07D295/10 , C07D295/116 , C07D295/12 , C07D295/145 , C07C97/10
Abstract: 1-Oxo-2-phenyl-2-(2-alkylaminoethyl)-1,2,3,4-tetrahydronaphthalenes of the formula I I where R1 and R2 are identical or different and are each hydrogen, halogen, trifluoromethyl, C1-C4-alkyl or C1-C4-alkoxy, R3 is C1-C6-alkyl and R4 is hydrogen, C1-C6-alkyl or benzyl, or R3 and R4 together may furthermore be a C2-C5-alkylene chain, and their salts with physiologically tolerated acids, and their preparation, are described. The novel compounds are useful active compounds for treating disorders.
-
公开(公告)号:DE3362130D1
公开(公告)日:1986-03-27
申请号:DE3362130
申请日:1983-11-11
Applicant: BASF AG
Inventor: TREIBER HANS JOERG DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR , TESCHENDORF HANS-JUERGEN DR , TRAUT MARTIN DR
IPC: A61K31/55 , A61P25/24 , A61P25/26 , C07D267/08 , C07D267/10
-
公开(公告)号:DE3361181D1
公开(公告)日:1985-12-12
申请号:DE3361181
申请日:1983-11-17
Applicant: BASF AG
Inventor: SEITZ WERNER DR , TESCHENDORF HANS-JUERGEN DR , MICHEL ALFRED DR , TRAUT MARTIN DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR
IPC: C07C225/18 , A61K31/135 , A61K31/205 , A61K31/395 , A61P25/24 , A61P25/26 , C07D207/08 , C07D211/32 , C07D295/10 , C07D295/116 , C07D295/12 , C07D295/145 , C07C97/10
Abstract: 1-Oxo-2-phenyl-2-(2-alkylaminoethyl)-1,2,3,4-tetrahydronaphthalenes of the formula I I where R1 and R2 are identical or different and are each hydrogen, halogen, trifluoromethyl, C1-C4-alkyl or C1-C4-alkoxy, R3 is C1-C6-alkyl and R4 is hydrogen, C1-C6-alkyl or benzyl, or R3 and R4 together may furthermore be a C2-C5-alkylene chain, and their salts with physiologically tolerated acids, and their preparation, are described. The novel compounds are useful active compounds for treating disorders.
-
公开(公告)号:DE3243158A1
公开(公告)日:1984-05-24
申请号:DE3243158
申请日:1982-11-23
Applicant: BASF AG
Inventor: SCHLECKER RAINER DR , SCHMIDT PETER DR , THIEME PETER C DR , LENKE DIETER PROF DR , TESCHENDORF HANS-JUERGEN DR ME , TRAUT MARTIN DR , MUELLER CLAUS D DR MED , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR
IPC: A61K31/35 , A61K31/352 , A61K31/365 , A61K31/37 , A61P25/18 , A61P25/24 , A61P25/26 , A61P37/08 , A61P43/00 , C07D311/08 , C07D311/16 , C07D311/78 , C07D311/80
Abstract: Sulfonates of hydroxycoumarins of the formula I (I) where R1 and R2 are identical or different and are each hydrogen, halogen or alkyl of 1 to 5 carbon atoms which can be substituted by -NR4R5, -OR4 or -OC(O)R4, where R4 and R5 are identical or different and are each hydrogen or alkyl of 1 to 4 carbon atoms, or R1 and R2 are each a carboxylic acid group -OC(O)R4 or a carboxamido radical, with the proviso that R1 is not methyl when R2 is hydrogen, or R1 and R2 together form a -(CH2)n- chain where n is 3-5, and R3 is a straight-chain or branched alkyl radical of 1 to 8 carbon atoms or cycloalkyl of 3 to 8 carbon atoms, each of which can be substituted by halogen, -OR4, -NR4R5, -CN or phenyl, or R3 is a straight-chain or branched alkenyl radical of 3 to 8 carbon atoms, an amino group - NR4R5, or phenyl or naphthyl, each of which is unsubstituted or monosubstituted or polysubstituted by -OR4, -NR4R5, -NO2, halogen, -SR4, -S(O)R4, -OS(O)R4, -SCF3, -OS(O)CF3, -CN, -C(O)R4, -OC(O)R4, -NHC(O)R4, -CF3, C1-C4-alkyl or a combination of these substituents, a process for their preparation, drugs containing these compounds, and compounds of the formula I, in which R1 is methyl and R2 is hydrogen, for use as drugs.
-
公开(公告)号:AT17945T
公开(公告)日:1986-02-15
申请号:AT83111275
申请日:1983-11-11
Applicant: BASF AG
Inventor: TREIBER HANS JOERG DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR , TESCHENDORF HANS-JUERGEN DR , TRAUT MARTIN DR
IPC: A61K31/55 , A61P25/24 , A61P25/26 , C07D267/08 , C07D267/10
-
公开(公告)号:AT16382T
公开(公告)日:1985-11-15
申请号:AT83111501
申请日:1983-11-17
Applicant: BASF AG
Inventor: SEITZ WERNER DR , TESCHENDORF HANS-JUERGEN DR , MICHEL ALFRED DR , TRAUT MARTIN DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR
IPC: C07C225/18 , A61K31/135 , A61K31/205 , A61K31/395 , A61P25/24 , A61P25/26 , C07D207/08 , C07D211/32 , C07D295/10 , C07D295/116 , C07D295/12 , C07D295/145 , C07C97/10
-
公开(公告)号:DE3360991D1
公开(公告)日:1985-11-14
申请号:DE3360991
申请日:1983-11-11
Applicant: BASF AG
Inventor: TREIBER HANS JOERG DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR , TESCHENDORF HANS-JURGEN DR , TRAUT MARTIN DR
IPC: A61K31/13 , A61K31/135 , A61K31/215 , A61K31/265 , A61P25/24 , A61P25/26 , C07C47/00 , C07C67/00 , C07C213/00 , C07C217/30 , C07C217/48 , C07C219/22 , C07C239/00 , C07C271/10 , C07C313/00 , C07C319/20 , C07C323/12 , C07C323/25 , C07D295/08 , C07D295/084 , C07D295/10 , C07D295/104 , C07C93/00 , C07C125/065 , C07C149/00
-
公开(公告)号:DE3226242A1
公开(公告)日:1984-01-26
申请号:DE3226242
申请日:1982-07-14
Applicant: BASF AG
Inventor: ALBRECHT HANS PETER DR , KREISKOTT HORST PROF DR
-
10.
公开(公告)号:DE3373655D1
公开(公告)日:1987-10-22
申请号:DE3373655
申请日:1983-11-12
Applicant: BASF AG
Inventor: SCHLECKER RAINER DR , SCHMIDT PETER DR , THIEME PETER C DR , LENKE DIETER PROF DR , TESCHENDORF HANS-JURGEN DR , TRAUT MARTIN DR , MUELLER CLAUS D DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR
IPC: A61K31/35 , A61K31/352 , A61K31/365 , A61K31/37 , A61P25/18 , A61P25/24 , A61P25/26 , A61P37/08 , A61P43/00 , C07D311/08 , C07D311/16 , C07D311/78 , C07D311/80
Abstract: Sulfonates of hydroxycoumarins of the formula I (I) where R1 and R2 are identical or different and are each hydrogen, halogen or alkyl of 1 to 5 carbon atoms which can be substituted by -NR4R5, -OR4 or -OC(O)R4, where R4 and R5 are identical or different and are each hydrogen or alkyl of 1 to 4 carbon atoms, or R1 and R2 are each a carboxylic acid group -OC(O)R4 or a carboxamido radical, with the proviso that R1 is not methyl when R2 is hydrogen, or R1 and R2 together form a -(CH2)n- chain where n is 3-5, and R3 is a straight-chain or branched alkyl radical of 1 to 8 carbon atoms or cycloalkyl of 3 to 8 carbon atoms, each of which can be substituted by halogen, -OR4, -NR4R5, -CN or phenyl, or R3 is a straight-chain or branched alkenyl radical of 3 to 8 carbon atoms, an amino group - NR4R5, or phenyl or naphthyl, each of which is unsubstituted or monosubstituted or polysubstituted by -OR4, -NR4R5, -NO2, halogen, -SR4, -S(O)R4, -OS(O)R4, -SCF3, -OS(O)CF3, -CN, -C(O)R4, -OC(O)R4, -NHC(O)R4, -CF3, C1-C4-alkyl or a combination of these substituents, a process for their preparation, drugs containing these compounds, and compounds of the formula I, in which R1 is methyl and R2 is hydrogen, for use as drugs.
-
-
-
-
-
-
-
-
-